Back to Search
Start Over
(E)-9-Octadecenoic Acid Ethyl Ester Derived from Lotus Seedpod Ameliorates Inflammatory Responses by Regulating MAPKs and NF- κ B Signalling Pathways in LPS-Induced RAW264.7 Macrophages.
- Source :
-
Evidence-based complementary and alternative medicine : eCAM [Evid Based Complement Alternat Med] 2022 Jan 05; Vol. 2022, pp. 6731360. Date of Electronic Publication: 2022 Jan 05 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- Inflammation is generally considered a key risk factor in the progress of several chronic diseases, such as arthritis, gastritis, and hepatitis. Natural products with anti-inflammatory ability have played a great role in the process of overcoming these inflammatory diseases. In this study, we evaluated the anti-inflammatory activities of ten natural compounds derived from lotus seedpod and discovered (E)-9-octadecenoic acid ethyl ester (E9OAEE) inhibited the production of nitric oxide (NO) optimally in lipopolysaccharide (LPS)-induced RAW264.7 macrophages. Furthermore, we explored the effects of E9OAEE on inflammatory responses and the underlying mechanisms in LPS-induced RAW264.7 macrophages. The results indicated that E9OAEE significantly suppressed the production of NO, prostaglandin E2 (PGE2), and tumour necrosis factor- α (TNF α ) in a dose-dependent manner. The protein expression and mRNA levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX2) were inhibited by pretreatment of E9OAEE. Furthermore, E9OAEE restrained the phosphorylation of mitogen-activated protein kinase (MAPKs) family members, ERK, P38, and JNK stimulated by LPS-treated for 30 min and prevented the nuclear translocation of nuclear factor-kappa B (NF- κ B) prompted by LPS-treated for 6 h in RAW264.7 macrophages. Taken together, we discovered an anti-inflammatory component from lotus seedpod and identified E9OAEE attenuated the inflammatory response in LPS-induced RAW264.7 macrophages probably by regulating the activation of MAPKs and NF- κ B signalling pathways, which would provide some base for the development of new anti-inflammatory drugs.<br />Competing Interests: The authors declare that there are no conflicts of interest.<br /> (Copyright © 2022 Chuanqi Xie et al.)
Details
- Language :
- English
- ISSN :
- 1741-427X
- Volume :
- 2022
- Database :
- MEDLINE
- Journal :
- Evidence-based complementary and alternative medicine : eCAM
- Publication Type :
- Academic Journal
- Accession number :
- 35035506
- Full Text :
- https://doi.org/10.1155/2022/6731360